- ASSOCIATE PROFESSOR | Pediatrics, Newborn Medicine
- Pediatrics Neonatal-Perinatal Medicine
- Chinese (Mandarin)
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- Klingenstein Pavillion Floor 3rd Room 14 212-241-6186212-241-6186
Dr. Jing Lin is an Associate Professor at the Icahn School of Medicine at Mount Sinai and an attending neonatologist in the Mount Sinai Health System. His primary focus is the clinical care of newborns in the NICU. Dr. Lin travels to China throughout the year as a visiting professor to promote pediatric and perinatal care. He has helped to create a modern NICU in Yuying Children’s Hospital of Wenzhou Medical University and works with the colleagues from the Canadian Neonatal Network on a project in Shanghai to train neonatologists in China. Dr. Lin is currently working in cooperation with the Chinese Graduate Medical Education Committee (CCGME) of the China Medical Doctors Association (CMDA) and the China Medical Board (CMB) to implement organized pediatric residency training and neonatology fellowship program for all of China.
- Necrotizing Enterocolitis
MD, Wenzhou Medical College
, University of Miami
Yuying Children's Hospital
New York University Medical Center
Mount Sinai Hospital
Chinese (Mandarin), English
Dr. Lin and his colleagues in China have performed an American Academy of Pediatrics-sponsored Neonatal Resuscitation Program-related research project. Other clinical studies related to neonatal infection, necrotizing enterocolitis, and retinopathy of prematurity are ongoing.
Xu Z, Chen Y, Yang M, Li W, Liu Q, Lin J. The epidemiological and clinical characteristics of measles in Wenzhou, China, 2000-2010. . Epidemiology and Infection 2014; 142: 20-27.
Bao S, Zhu L, Zhuang Q, Wang L, Xu P, Itoh K, Holzman I, Lin J. Distribution dynamics of recombinant Lactobacillus in the gastrointestinal tract of neonatal rats. . PLOS ONE 2013; 8: e60007.
Jia Y, Lin Z, Lv H, Li Y, Green R, Lin J. Effect of Delivery Room Temperature on the Admission Temperature of Premature Infants-A Randomized Controlled Trial. . J Perinatol 2013; 33: 264-7.
Adrouche-Amrani L, Green R, Gluck K, Lin J. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.. BMC Pediatr 2012; 12(10).
Liu X, Zhou R, Pan Q, Jia X, Gao W, Wu J, Lin J, Chen J. Genetic inactivation of the adenosine A2A receptor attenuates pathological but not developmental angiogenesis in mouse retina. . Invest Ophthalmol Vis Sci. 2010; 51: 6625-6632.
Chen S, Chen J, Cai X, Gao Y, Ge R, Wu H, Lin Z, Lin J. Perinatal exposure to di-(2-ethylhexyl) phthalate leads to restricted growth and delayed lung maturation in newborn rats. . J Perinat Med 2010; 38: 515-521.
Peng L, Li Z, Green R, Holzman I, Lin J. Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP Activated Protein Kinase in Caco-2 Cell Monolayers. . J Nutr ; 139: 1619-25.
Peng L, He Z, Chen W, Holzman I, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model.. Pediatr Res 2007; 61: 37-41.
Lin Z, Yu H, Lin J, Chen S, Liang Z, Zhang Z. Mild hypothermia via selective head cooling as neuroprotective therapy in term neonates with perinatal asphyxia: an experience from a single neonatal intensive care unit. . J Perinatol 2006; 26: 180-184.
Lin J, Peng L, Itzkowitz S, Holzman I, Babyatsky M. Short-chain fatty acid induces intestinal mucosal injury in newborn rats and down-regulates intestinal trefoil factor gene expression in vivo and in vitro. . J Pediatr Gastr Nutr 2005; 41: 607-611.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Lin did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.